My Financial News from Tabuk, Saudi Arabia

from Bing and Google News
Saudi Arabia , Thursday 15 October 2026

TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA

Published on: Monday 29 September 2025

TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA Specialty pharmaceutical companies Tabuk Pharmaceutical Manufacturing Company a fully owned subsidiary of Astra Industrial Group and a leading pharmaceutical company in the Middle East and Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the launch of Cumberland's Vibativ® (telavancin) injection in Saudi Arabia.


News source: https://finance.yahoo.com/news/tabuk-launches-vibativ-fda-approved-130500725.html

Share this news on:  

RELATED NEWS

» TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA
» Saudi Arabia Pharmaceutical CDMO Market Research Report 2025 Featuring Tabuk Manufacturing, Lifera, Saudi Bio, Fresenius Kabi, Hikma Pharma, Pfizer, Novartis
» People in Saudi Arabia visit mountain to experience the cold weather
» Royal Saudi Land Forces and Egyptian Armed Forces Continue Executing 'Tabuk-5' Exercise
» Jabal Al-Lawz in Saudi Arabia's Tabuk Region Blanketed with Snow

HEADLINE NEWS